Two-days international conference on advances in blood cancer diagnosis and treatment
Hyderabad, 22nd February, 2025: “Deccan Hematolink 2.0” is the largest international conference on blood cancers, with over 200 national and 10 international oncology and hemato-oncology medical experts participating at Yashoda Hospitals Hitech City to discuss the latest advances in blood cancer diagnosis, treatment and patient care. As part of this two days conference conducted on 22nd & 23rd February, Yashoda Group Hospitals Managing Director, Dr. G. S. Rao, inaugurated the conference as the Chief Guest on the first day today i.e. 22nd February 2025.
Speaking on this occasion, Dr. G. S. Rao, Managing Director, Yashoda Group Hospitals, said that fighting blood cancer is not just about medical treatment, it also requires mental strength, financial support and community awareness. Rising Burden of Blood Cancers in India. According to the GLOBOCAN 2020 report, India sees around 1.3 million new cancer cases annually, with blood cancers forming a significant proportion. The National Cancer Registry Programme highlights a growing prevalence of leukemia, lymphoma, and myeloma, particularly in urban centers like Hyderabad. The high incidence of blood cancers emphasizes the need for early detection, advanced treatments, and accessible care for all. Until recently, many blood cancer patients had limited treatment options. However, the advances now available in cancer treatment from bone marrow transplants to cutting-edge immunotherapies like CAR-T cell therapy are revolutionising cancer treatment, offering new hope to cancer patients, said Dr. G. S. Rao.
Yashoda Hospitals-Hitech City, Senior Hematologist, Dr. Ganesh Jaishetwar, said Yashoda Hospitals, in the last 12 years, proudly announced that it has performed more than 500 successful bone marrow transplants and treated thousands of blood cancer patients, giving them a new lease of life. He said that in traditional blood cancer treatment, many blood cancer patients had limited treatment options till now, but now the availability of cutting-edge world-class treatment methods like • Targeted therapies, • CAR-T cell therapy, • Gene therapy has changed the face of hematologic care.
He said that Bone Marrow Transplant (BMT) is a critical treatment option for leukemia, lymphoma, myeloma, thalassemia, immunodeficiency disorders, genetic diseases and aplastic anemia. Now the most advanced and latest treatment in blood cancer treatment is CAR-T cell therapy. It regenerates the patient’s immune cells to attack the cancer. Till now CAR-T therapy was a very expensive cancer treatment available only abroad, now Indian pharmaceutical companies have developed indigenous CAR-T therapies and made them available at affordable prices.
At Yashoda Hospital, Hitech City, we are committed to providing world-class treatment to every blood cancer patient who needs it. Blood cancer is no longer a death sentence, with early diagnosis, precise treatment options. Survival rates are increasing significantly with cutting-edge treatments like CAR-T cell therapy and bone marrow transplant, said Dr. Ganesh Jaishetwar.
